Hospital costs for treatment of acute heart failure: economic analysis of the REVIVE II study

Greg Lissovoy (), Kathy Fraeman, John Teerlink, John Mullahy (), Jeff Salon, Raimund Sterz, Amy Durtschi and Robert Padley

The European Journal of Health Economics, 2010, vol. 11, issue 2, 185-193

Keywords: Acute heart failure; Inotropes; Levosimendan; Dobutamine; Cost-effectiveness; Pharmacoeconomics; Health care; Hospitalization; I11 (search for similar items in EconPapers)
Date: 2010
References: View complete reference list from CitEc
Citations: View citations in EconPapers (1)

Downloads: (external link)
http://hdl.handle.net/10.1007/s10198-009-0165-2 (text/html)
Access to full text is restricted to subscribers.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:spr:eujhec:v:11:y:2010:i:2:p:185-193

Ordering information: This journal article can be ordered from
http://www.springer. ... cs/journal/10198/PS2

DOI: 10.1007/s10198-009-0165-2

Access Statistics for this article

The European Journal of Health Economics is currently edited by J.-M.G.v.d. Schulenburg

More articles in The European Journal of Health Economics from Springer, Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ) Contact information at EDIRC.
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().